Article
Three‐dimensional porous scaffolds at the crossroads of tissue engineering and cell‐based gene therapy
13 Aug 2009
Abstract excerpt
In the last 20 years, more than 1,500 gene therapy clinical trials have been approved worldwide targeting a variety of indications, from inherited monogenic diseases to acquired conditions such as cancer, cardiovascular and infectious diseases. However, concerns about the safety and efficacy of gene therapy pharmaceuticals justify the development of alternative strategies to ensure the clinical translation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
